PH
IXICO plc
PHYOF · OTC
$0.07 +0.00% (+$0.00)
Market Cap £4.92M
P/E Ratio -
Div. Yield -
ROE 14.93%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.42x
P/S 0.75x
EV/EBITDA N/A
Growth
3 /100
Declining Book val. growth 2.06%
Rev. growth 8.90%
FCF growth N/A
Profitability
19 /100
Weak Net margin 25.27%
Op. margin 39.09%
FCF margin 28.73%
Quality
6 /100
Poor ROE 14.93%
ROA 11.93%
Asset turnover 0.47x
Debt
69 /100
Low Current ratio 3.03x
Int. coverage -152.06x
Debt/Equity 0.02x
Stability
19 /100
Unstable Rev. volatility 18.79%
EPS volatility 137.95%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PHYOF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bram Goorden
Employees
79
Headquarters
London
Prihajajoči dogodki
08 DEC.
Earnings
Upcoming earnings report